Vitamin D levels in children and adolescents with obsessive compulsive disorder

References

• Heyman I, Mataix-Cols D, Fineberg NA. Obsessive-compulsive disorder. BMJ. 2006;333:424–429.
   PubMed Web of Science ®Google Scholar
• Stewart SE, Geller DA, Jenike M, et al. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand. 2004;110:4–13.
   PubMed Web of Science ®Google Scholar
• Storch EA, Larson MJ, Muroff J, et al. Predictors of functional impairment in pediatric obsessive-compulsive disorder. J Anxiety Disord. 2010;24:275–283.
   PubMed Web of Science ®Google Scholar
• McGuire JF, Lewin AB, Horng B, et al. The nature, assessment, and treatment of obsessive-compulsive disorder. Postgrad Med. 2012;124:152–165.
   PubMed Web of Science ®Google Scholar
• Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 2012;51:98–113.
   PubMed Web of Science ®Google Scholar
• Abudy A, Juven-Wetzler A, Zohar J. Pharmacological management of treatment-resistant obsessive-compulsive disorder. CNS Drugs. 2011;25:585–596.
   PubMed Web of Science ®Google Scholar
• DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80:1689S–1696S.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Burne TH, McGrath JJ. Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol. 2013;34:47–64.
   PubMed Web of Science ®Google Scholar
• Kiraly SJ, Kiraly MA, Hawe RD, et al. Vitamin D as a neuroactive substance: review. ScientificWorldJournal. 2006;6:125–139.
   PubMedGoogle Scholar
• Wrzosek M, Łukaszkiewicz J, Wrzosek M, et al. Vitamin D and the central nervous system. Pharmacol Rep. 2013;65:271–278.
   PubMed Web of Science ®Google Scholar
• McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? Faseb J. 2008;22:982–1001.
   PubMed Web of Science ®Google Scholar
• Brown J, Bianco JI, McGrath JJ, et al. 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett. 2003;343:139–143.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D and brain health: the need for vitamin D supplementation and sensible sun exposure. J Intern Med. 2015;277:90–93.
   PubMed Web of Science ®Google Scholar
• Goksugur SB, Tufan AE, Semiz M, et al. Vitamin D status in children with attention-deficit-hyperactivity disorder. Pediatr Int. 2014;56:515–519.
   PubMed Web of Science ®Google Scholar
• Chiang M, Natarajan R, Fan X. Vitamin D in schizophrenia: a clinical review. Evid Based Ment Health. 2016;19:6–9.
   PubMed Web of Science ®Google Scholar
• Wang T, Shan L, Du L, et al. Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2016;25:341–350.
   PubMed Web of Science ®Google Scholar
• Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord. 2017;208:56–61.
   PubMed Web of Science ®Google Scholar
• Föcker M, Antel J, Ring S, et al. Vitamin D and mental health in children and adolescents. Eur Child Adolesc Psychiatry. 2017;26:1043–1066.
   PubMed Web of Science ®Google Scholar
• Harms LR, Turner KM, Eyles DW, et al. Attentional processing in C57BL/6J mice exposed to developmental vitamin D deficiency. PLoS One. 2012;7:e35896.
   PubMed Web of Science ®Google Scholar
• Boileau B. A review of obsessive-compulsive disorder in children and adolescents. Dialogues Clin Neurosci. 2011;13:401–411.
   PubMedGoogle Scholar
• Westenberg HG, Fineberg NA, Denys D. Neurobiology of obsessive-compulsive disorder: serotonin and beyond. CNS Spectr. 2007;12:14–27.
   Web of Science ®Google Scholar
• Koo MS, Kim EJ, Roh D, et al. Role of dopamine in the pathophysiology and treatment of obsessive-compulsive disorder. Expert Rev Neurother. 2010;10:275–290.
   PubMed Web of Science ®Google Scholar
• Kariuki–Nyuthe C, Gomez–Mancilla B, Stein DJ. Obsessive compulsive disorder and the glutamatergic system. Curr Opin Psychiatry. 2014;27:32–37.
   PubMed Web of Science ®Google Scholar
• Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292:1969–1976.
   PubMed Web of Science ®Google Scholar
• Bloch MH, Landeros-Weisenberger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006;11:622–632.
   PubMed Web of Science ®Google Scholar
• Afshar H, Roohafza H, Mohammad-Beigi H, et al. N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2012;32:797–803.
   PubMed Web of Science ®Google Scholar
• Sanchez B, Relova JL, Gallego R, et al. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J Neurosci Res. 2009;87:723–732.
   PubMed Web of Science ®Google Scholar
• Cui X, Pertile R, Liu P, et al. Vitamin D regulates tyrosine hydroxylase expression: N-cadherin a possible mediator. Neuroscience. 2015;304:90–100.
   PubMed Web of Science ®Google Scholar
• Kaneko I, Sabir MS, Dussik CM, et al. 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D. Faseb J. 2015;29:4023–4035.
   PubMed Web of Science ®Google Scholar
• Kuloglu M, Atmaca M, Tezcan E, et al. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology. 2002;46:27–32.
   PubMed Web of Science ®Google Scholar
• Behl A, Swami G, Sircar SS, et al. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology. 2010;61:210–214.
   PubMed Web of Science ®Google Scholar
• Shinpo K, Kikuchi S, Sasaki H, et al. Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine. J Neurosci Res. 2000;62:374–382.
   PubMed Web of Science ®Google Scholar
• Dawson VL, Dawson TM. Nitric oxide actions in neurochemistry. Neurochem Int. 1996;29:97–110.
   PubMed Web of Science ®Google Scholar
• Garcion E, Sindji L, Montero-Menei C, et al. Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia. 1998;22:282–294.
   PubMed Web of Science ®Google Scholar
• Garcion E, Wion-Barbot N, Montero-Menei CN, et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13:100–105.
   PubMed Web of Science ®Google Scholar
• Atmaca M, Tezcan E, Kuloglu M, et al. Plasma nitrate values in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci. 2005;59:621–623.
   PubMed Web of Science ®Google Scholar
• Neveu I, Naveilhan P, Jehan F, et al. 1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res. 1994;24:70–76.
   PubMedGoogle Scholar
• Neveu I, Naveilhan P, Baudet C, et al. 1,25-Dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport. 1994;6:124–126.
   PubMed Web of Science ®Google Scholar
• Naveilhan P, Neveu I, Wion D, et al. 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport. 1996;7:2171–2175.
   PubMed Web of Science ®Google Scholar
• Riaz S, Malcangio M, Miller M, et al. A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocin-diabetic rats. Diabetologia. 1999;42:1308–1313.
   PubMed Web of Science ®Google Scholar
• Fontenelle LF, Barbosa IG, Luna JV, et al. Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res. 2012;199:195–200.
   PubMed Web of Science ®Google Scholar
• Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am. 2000;23:563–586.
   PubMed Web of Science ®Google Scholar
• Piras F, Piras F, Caltagirone C, et al. Brain circuitries of obsessive compulsive disorder: a systematic review and meta-analysis of diffusion tensor imaging studies. Neurosci Biobehav Rev. 2013;37:2856–2877.
   PubMed Web of Science ®Google Scholar
• Piras F, Piras F, Chiapponi C, et al. Widespread structural brain changes in OCD: a systematic review of voxel-based morphometry studies. Cortex. 2015;62:89–108.
   PubMed Web of Science ®Google Scholar
• Fibbe LA, Cath DC, van den Heuvel OA, et al. Relationship between movement disorders and obsessive-compulsive disorder: beyond the obsessive-compulsive-tic phenotype. A systematic review. J Neurol Neurosurg Psychiatry. 2012;83:646–654.
   PubMed Web of Science ®Google Scholar
• Eyles DW, Smith S, Kinobe R, et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29:21–30.
   PubMed Web of Science ®Google Scholar
• Ibi M, Sawada H, Nakanishi M, et al. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology. 2001;40:761–771.
   PubMed Web of Science ®Google Scholar
• Çelik G, Taş D, Tahiroğlu A, et al. Vitamin D deficiency in obsessive-compulsive disorder patients with Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections: a case control study. Arch Neuropsychiatr. 2016;53:33–37.
   Google Scholar
• Esnafoğlu E, Yaman E. Vitamin B12, folic acid, homocysteine and vitamin D levels in children and adolescents with obsessive compulsive disorder. Psychiatry Res. 2017;254:232–237.
   PubMed Web of Science ®Google Scholar
• Celik G, Tas DA, Varmıs DA, et al. Vitamin D insufficiency in a boy with obsessive-compulsive disorder. Pediatr Int. 2016;58:646–648.
   PubMed Web of Science ®Google Scholar
• Kaufman J, Birmaher B, Brent D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36:980–988.
   PubMed Web of Science ®Google Scholar
• Axelson D, Birmaher B, Zelazny J, et al. The Schedule for Affective Disorders and Schizophrenia – Present and Lifetime Version (KSADSPL) 2009 Working Draft. 2009. Advanced Centre for Intervention and Services Research, Western Psychiatric Institute and Clinic.
   Google Scholar
• Gokler B, Unal F, Pehlivanturk B, et al. Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-Turkish version (K-SADS-PL-T). Turk J Child Adolesc Ment Health. 2004;11:109–116.
   Google Scholar
• Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry. 1997;36:844–852.
   PubMed Web of Science ®Google Scholar
• Yucelen AG, Rodopman-Arman A, Topcuoglu V, et al. Interrater reliability and clinical efficacy of Children’s Yale-Brown Obsessive-Compulsive Scale in an outpatient setting. Comprehensive Psychiatry. 2006;47:48–53.
   PubMed Web of Science ®Google Scholar
• Kovacs M. The Children's Depression, Inventory (CDI). Psychopharmacol Bull. 1985;21:995–998.
   PubMed Web of Science ®Google Scholar
• Oy B. The children’s depression inventory: validity and reliability study. Turk J Psychiatry. 1991;2:132–136.
   Google Scholar
• Savasir I, Sahin N. Wechsler Çocuklar İçin Zeka Ölçeği (WISC-R). Turkish Psychological Association, Ankara. 1995 (Turkish).
   Google Scholar
• Bičíková M, Dušková M, Vítků J, et al. Vitamin D in anxiety and affective disorders. Physiol Res. 2015;64(Suppl2):S101–S103.
   Web of Science ®Google Scholar
• Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008;87:1080S–1086S.
   PubMed Web of Science ®Google Scholar
• Stengler K, Olbrich S, Heider D, et al. Mental health treatment seeking among patients with OCD: impact of age of onset. Soc Psychiatry Psychiatr Epidemiol. 2013;48:813–819.
   PubMed Web of Science ®Google Scholar
• Brady CF. Obsessive-compulsive disorder and common comorbidities. J Clin Psychiatry. 2014;75:e02.
   PubMed Web of Science ®Google Scholar